Bridgewater Associates’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.07M Buy
33,993
+2,765
+9% +$254K 0.01% 543
2025
Q4
$2.81M Buy
31,228
+18,679
+149% +$1.77M 0.01% 690
2025
Q3
$1.24M Buy
12,549
+5,988
+91% +$593K ﹤0.01% 821
2025
Q2
$598K Sell
6,561
-1,960
-23% -$190K ﹤0.01% 504
2025
Q1
$964K Sell
8,521
-191,972
-96% -$20.5M ﹤0.01% 523
2024
Q4
$21.2M Buy
200,493
+19,866
+11% +$2.13M 0.1% 161
2024
Q3
$19.5M Sell
180,627
-170,948
-49% -$18.7M 0.11% 158
2024
Q2
$38.2M Sell
351,575
-3,328
-0.9% -$392K 0.2% 85
2024
Q1
$46.8M Buy
354,903
+35,736
+11% +$4.46M 0.24% 78
2023
Q4
$38.8M Buy
319,167
+23,634
+8% +$2.64M 0.22% 83
2023
Q3
$33.2M Buy
295,533
+41,353
+16% +$5.25M 0.2% 92
2023
Q2
$37M Sell
254,180
-39,390
-13% -$5.35M 0.23% 84
2023
Q1
$37.9M Sell
293,570
-22,930
-7% -$2.88M 0.23% 87
2022
Q4
$40.4M Sell
316,500
-84,479
-21% -$9.8M 0.22% 93
2022
Q3
$41.9M Buy
400,979
+7,223
+2% +$793K 0.21% 94
2022
Q2
$41.4M Sell
393,756
-20,154
-5% -$2.39M 0.18% 115
2022
Q1
$52.9M Buy
413,910
+142,530
+53% +$17.2M 0.21% 81
2021
Q4
$33.5M Buy
271,380
+44,978
+20% +$5.89M 0.19% 96
2021
Q3
$32.2M Buy
226,402
+6,441
+3% +$947K 0.18% 104
2021
Q2
$34.3M Buy
219,961
+90,550
+70% +$14.7M 0.22% 86
2021
Q1
$20.1M Buy
129,411
+18,701
+17% +$2.9M 0.18% 105
2020
Q4
$16.6M Buy
110,710
+60,025
+118% +$8.48M 0.14% 93
2020
Q3
$6.7M Buy
+50,685
New +$6.62M 0.08% 112
2020
Q2
Sell
-6,546
Closed -$642K 523
2020
Q1
$642K Buy
+6,546
New +$858K 0.01% 259
2017
Q1
Sell
-22,454
Closed -$2.25M 325
2016
Q4
$2.25M Buy
+22,454
New +$2.41M 0.02% 189
2016
Q1
Sell
-6,498
Closed -$647K 312
2015
Q4
$647K Sell
6,498
-12,360
-66% -$1.21M 0.01% 230
2015
Q3
$1.72M Buy
18,858
+3,791
+25% +$380K 0.02% 199
2015
Q2
$1.6M Buy
+15,067
New +$1.67M 0.01% 204
2015
Q1
Sell
-2,089
Closed -$230K 406
2014
Q4
$230K Buy
+2,089
New +$220K ﹤0.01% 301
2014
Q1
Sell
-6,996
Closed -$633K 392
2013
Q4
$633K Sell
6,996
-3,811
-35% -$330K 0.01% 276
2013
Q3
$862K Sell
10,807
-52,590
-83% -$4.14M 0.01% 218
2013
Q2
$4.61M Buy
+63,397
New +$4.74M 0.04% 89

Other funds holding ZBH

Bridgewater Associates's ZBH Position: Q1 2026 in Review

Bridgewater Associates increased its Zimmer Biomet (ZBH) stake by 8.9% in Q1 2026, buying an estimated $254K and bringing the position to 33,993 shares worth $3.07M. The position accounts for 0.01% of the portfolio, ranked #543.

Bridgewater Associates first reported a position in ZBH in Q2 2013 and has held it in 32 quarters since. The position peaked at $52.9M in Q1 2022. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Bridgewater Associates held 33,993 shares of Zimmer Biomet worth $3.07M as of Q1 2026.
  • Bridgewater Associates bought 2,765 Zimmer Biomet shares in Q1 2026, an estimated $254K.
  • Zimmer Biomet made up 0.01% of Bridgewater Associates's portfolio in Q1 2026, its #543 holding.
  • Bridgewater Associates first reported a position in Zimmer Biomet in Q2 2013 and has held it in 32 quarters since.
  • Bridgewater Associates's Zimmer Biomet position peaked at $52.9M in Q1 2022.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.